Beta-blockers or prostaglandins: which is the better choice?

被引:0
作者
Denis, P. [1 ]
机构
[1] Hop Edouard Herriot, Serv Ophtalmol, Pavillon C, F-69437 Lyon 03, France
来源
JOURNAL FRANCAIS D OPHTALMOLOGIE | 2009年 / 32卷 / 03期
关键词
Beta-blockers; Glaucoma; Medical treatment; Prostaglandin analogues; OPEN-ANGLE GLAUCOMA; INITIAL MEDICAL-TREATMENT; OCULAR-HYPERTENSION; INTRAOCULAR-PRESSURE; RESOURCE UTILIZATION; COMBINATION THERAPY; RISING COST; LATANOPROST; TIMOLOL; DRUGS;
D O I
10.1016/j.jfo.2009.03.015
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
The predominant place of topical beta-blockers as first-tine, initial treatment for glaucoma and ocular hypertension is currently challenged with the availabitity of topical prostaglandin analogues. We present and discuss available data and arguments to permit to the ophthalmologist the better choice, individually tailored to a given patient, between these two therapeutic classes. (C) 2009 Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:206 / 211
页数:6
相关论文
共 23 条